(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KWALEP

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

KWALEP

ST13

US500000079319135

Class

5

Filing

79319135

Registration

6914875

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

05/14/2024

Trademark type

Word

Nice classes

5

Filing date

07/07/2021

Registration date

12/06/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/06/2022

Last transaction

08/19/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

Ibaraki- shi Osaka, JP

Examiner

STADELI, MARTA ANN

Law office

N50

Current location

TMO LAW OFFICE 123

Holders and representatives

Holders

KRINGLE PHARMA, INC.

Representatives

Sandra Epp Ryan HAMRE, SCHUMANN, MUELLER & LARSON, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of nerve system diseasesrenal diseaserespiratory system diseasesskin diseases and scar tissue

Publications

History of USPTO decisions and trademark events.

29 publications found

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

05/14/2024

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

04/05/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/25/2024

ES7R

TEAS SECTION 7 REQUEST RECEIVED

08/09/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/19/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/24/2023

FIMP

FINAL DISPOSITION PROCESSED

03/24/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/06/2023

GPNX

NOTIFICATION PROCESSED BY IB

12/28/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/06/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/06/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/20/2022

PUBO

PUBLISHED FOR OPPOSITION

09/20/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/07/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/07/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/31/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/17/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/22/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/21/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/21/2022

RFNT

REFUSAL PROCESSED BY IB

05/30/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/06/2022

RFRR

REFUSAL PROCESSED BY MPU

05/06/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/28/2022

CNRT

NON-FINAL ACTION WRITTEN

03/27/2022

DOCK

ASSIGNED TO EXAMINER

03/27/2022

MAFR

APPLICATION FILING RECEIPT MAILED

09/11/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/07/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/02/2021

Continuous trademark protection

Get notified about every new filing that threatens KWALEP or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.